MDUFA V: Industry, FDA Tangle Over TAP Program, Agency Finances, Reinstatement Of Fifth-Year Offset Funds
Executive Summary
In newly published meeting minutes, industry and the US FDA continued to clash over a proposal to create a new pre-submission advisory program and what to do with carryover user-fee funds.
You may also be interested in...
Pop The Champagne: Medtech Industry, FDA Reach MDUFA V User-Fee Deal
The deal includes a $110m Total Product Lifecycle Advisory Program pushed for by the US agency, but also credits unused funds past a certain threshold back to industry.
FDA Looking For A Few Good Contractors To Guide Digital Modernization
The US regulatory agency is looking for qualified independent contractors to help guide upgrades to its IT systems, make recommendations and report on how things are going.
Top Senator ‘Disappointed’ With Missing MDUFA Package
Sen. Patty Murray said she doesn’t want more uncertainty about user fees during the COVID-19 pandemic and will move to get all the user fees renewed before they expire in September.